A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors
Clinical trial NCT02593786 · COMPLETED
Trial details
- NCT number
- NCT02593786
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-07
- Primary completion
- 2021-09-27
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.